1521 related articles for article (PubMed ID: 8293279)
21. Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells.
Alberati-Giani D; Ricciardi-Castagnoli P; Köhler C; Cesura AM
J Neurochem; 1996 Mar; 66(3):996-1004. PubMed ID: 8769859
[TBL] [Abstract][Full Text] [Related]
22. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
23. Species differences in L-tryptophan-kynurenine pathway metabolism: quantification of anthranilic acid and its related enzymes.
Fujigaki S; Saito K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
Arch Biochem Biophys; 1998 Oct; 358(2):329-35. PubMed ID: 9784247
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis.
Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati PJ; Brew BJ
Redox Rep; 2000; 5(2-3):108-11. PubMed ID: 10939285
[TBL] [Abstract][Full Text] [Related]
25. 4-chloro-3-hydroxyanthranilate reduces local quinolinic acid synthesis, improves functional recovery, and preserves white matter after spinal cord injury.
Yates JR; Heyes MP; Blight AR
J Neurotrauma; 2006 Jun; 23(6):866-81. PubMed ID: 16774472
[TBL] [Abstract][Full Text] [Related]
26. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
Heyes MP; Saito K; Devinsky O; Nadi NS
Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
[TBL] [Abstract][Full Text] [Related]
27. Altered tryptophan metabolism in mice with herpes simplex virus encephalitis: increases in spinal cord quinolinic acid.
Reinhard JF
Neurochem Res; 1998 May; 23(5):661-5. PubMed ID: 9566604
[TBL] [Abstract][Full Text] [Related]
28. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
[TBL] [Abstract][Full Text] [Related]
29. Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation.
Mechtcheriakov S; Gleissenthall GV; Geisler S; Arnhard K; Oberacher H; Schurr T; Kemmler G; Unterberger C; Fuchs D
Alcohol Clin Exp Res; 2022 Sep; 46(9):1648-1656. PubMed ID: 35938556
[TBL] [Abstract][Full Text] [Related]
30. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review.
Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Mohamadkhani A; Klegeris A; McElhinney A; Mafi Z; Hajiesmaeili M; Sayehmiri F
Front Immunol; 2022; 13():1013784. PubMed ID: 36426364
[TBL] [Abstract][Full Text] [Related]
31. Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase.
Chiarugi A; Moroni F
Neuropharmacology; 1999 Aug; 38(8):1225-33. PubMed ID: 10462134
[TBL] [Abstract][Full Text] [Related]
32. Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children.
Heyes MP; Saito K; Milstien S; Schiff SJ
J Neurol Sci; 1995 Nov; 133(1-2):112-8. PubMed ID: 8583213
[TBL] [Abstract][Full Text] [Related]
33. Quinolinic acid accumulation and functional deficits following experimental spinal cord injury.
Blight AR; Cohen TI; Saito K; Heyes MP
Brain; 1995 Jun; 118 ( Pt 3)():735-52. PubMed ID: 7600090
[TBL] [Abstract][Full Text] [Related]
34. Expression of the kynurenine pathway enzymes in human microglia and macrophages.
Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ
Adv Exp Med Biol; 2003; 527():105-12. PubMed ID: 15206722
[TBL] [Abstract][Full Text] [Related]
35. Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice.
Saito K; Markey SP; Heyes MP
Brain Res; 1991 Apr; 546(1):151-4. PubMed ID: 1830237
[TBL] [Abstract][Full Text] [Related]
36. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
[TBL] [Abstract][Full Text] [Related]
37. Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques.
Saito K; Lackner A; Markey SP; Heyes MP
Brain Res; 1991 Feb; 540(1-2):353-6. PubMed ID: 1647247
[TBL] [Abstract][Full Text] [Related]
38. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of [5-3H]kynurenine in the rat brain in vivo: evidence for the existence of a functional kynurenine pathway.
Guidetti P; Eastman CL; Schwarcz R
J Neurochem; 1995 Dec; 65(6):2621-32. PubMed ID: 7595559
[TBL] [Abstract][Full Text] [Related]
40. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
